China Resources Boya Bio pharmaceutical Group Co Ltd Cash Flow Quality Index
China Resources Boya Bio pharmaceutical Group Co Ltd cash flow quality index. China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a Cash Flow Quality Index of 0.37x as of September 2025. Operating cash flow of CN¥43.70 Million is below net income of CN¥117.62 Million, suggesting accrual-heavy earnings not yet converted to cash. See China Resources Boya Bio pharmaceutical financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
Cash flow quality index of China Resources Boya Bio pharmaceutical Group Co Ltd from 2009 to 2025. Historical Cash Flow Quality Index for China Resources Boya Bio pharmaceutical Group Co Ltd across 17 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can China Resources Boya Bio pharmaceutical service its debt to assess how comfortably operating cash covers total debt obligations.
China Resources Boya Bio pharmaceutical Group Co Ltd Cash Flow Quality Index by Year (2009–2025)
China Resources Boya Bio pharmaceutical Group Co Ltd cash flow quality index by year from 2009 to 2025. Year-by-year earnings quality comparison for China Resources Boya Bio pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of China Resources Boya Bio pharmaceutical .
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.04x | CN¥116.69 Million | CN¥112.70 Million | ▲ +37.1% |
| 2024 | 0.76x | CN¥299.78 Million | CN¥396.99 Million | ▼ -72.1% |
| 2023 | 2.70x | CN¥641.73 Million | CN¥237.47 Million | ▲ +101.8% |
| 2022 | 1.34x | CN¥596.44 Million | CN¥445.49 Million | ▼ -64.3% |
| 2021 | 3.76x | CN¥1.35 Billion | CN¥358.28 Million | ▲ +43.8% |
| 2020 | 2.61x | CN¥718.58 Million | CN¥275.26 Million | ▲ +1107.9% |
| 2019 | -0.26x | CN¥-114.51 Million | CN¥442.12 Million | ▼ -460.0% |
| 2018 | 0.07x | CN¥34.90 Million | CN¥485.08 Million | ▲ +210.3% |
| 2017 | -0.07x | CN¥-23.82 Million | CN¥364.93 Million | ▼ -109.1% |
| 2016 | 0.72x | CN¥198.76 Million | CN¥277.55 Million | ▼ -18.6% |
| 2015 | 0.88x | CN¥147.02 Million | CN¥167.05 Million | ▼ -16.8% |
| 2014 | 1.06x | CN¥121.88 Million | CN¥115.20 Million | ▼ -2.2% |
| 2013 | 1.08x | CN¥89.11 Million | CN¥82.36 Million | ▼ -12.0% |
| 2012 | 1.23x | CN¥92.36 Million | CN¥75.15 Million | ▼ -1.7% |
| 2011 | 1.25x | CN¥81.53 Million | CN¥65.23 Million | ▲ +152.2% |
| 2010 | 0.50x | CN¥24.77 Million | CN¥49.98 Million | ▼ -69.9% |
| 2009 | 1.65x | CN¥51.88 Million | CN¥31.51 Million | — |